Radiotherapy in the Treatment of Stage III-IV Hypopharyngeal Carcinoma

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 349-354

  Tombolini, Vincenzo ^a,c   Santarelli, Mario ^b   Raffetto, Nicola ^b   Donato, Vittorio ^b   Valeriani, Maurizio ^c   Ferretti, Antonio ^a   Enrici, R Maurizi ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

Author keywords

Advanced stage; Exclusive radiotherapy; Hypopharyngeal cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HYPOPHARYNX CARCINOMA; LYMPH NODE; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 1442277053     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parker SL, Tong T, Bolden S et al: Cancer statistic, 1997. CA Cancer J Clin 47: 5-27, 1997.
2. Truluck Ch and Putney FS: Survival rate in cancer of the tongue, tonsil and hypopharynx. Arch Otolaringol 93(3): 271-274, 1971.
3. TNM. Classification of Malignant Tumors, 4th ed Heidelberg, New York, London, Paris, Tokio: Springer Verlag, 1987.
4. Rubin P: Late effects on normal tissue (LENT) Consensus Conference. Radiat Oncol Biol Phys 31: 1035-1367, 1995.
5. Pingree TF, Davis RK, Reichman O and Derrick L: Treatment of hypopharyngeal carcinoma: a 10-year rewiew of 1362 cases. Laryngoscope 97: 901-904, 1987.
6. Wight RG, Birchall MA, Stafford ND and Stanbridge RL: Management of hypopharyngeal carcinoma: a 6-year review. J R Soc Med 85: 545-547, 1992.
7. Godballe C, Jorgensen K, Hansen O and Bastholt L: Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. Laryngoscope 112: 834-838, 2002.
8. Leventag PC, Nowak PJCM, van der Sangen MJC, Jansen PP, Eijkenboom WMH, Planting AST, Meeuwis CA and van Putten WLJ: Local tumor control in radiation therapy of cancer in the head and neck. Am J Clin Oncol 19(5): 469-477, 1996.
9. Laramore GE, Scott CB, al-Sarraf M et al: Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck: report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 23: 705-13, 1992.
10. Emami B, Marks JE, Senunus L et al: Carcinoma of the pharyngeal wall. Proceedings of the Second World Congress on Laryngeal Cancer, Amsterdam, The Netherlands, 1994.
11. Spector G, Sessions D, Emami B et al: Carcinoma of the aryepiglottic fold: Therapeutic results and long time follow-up. Laryngoscope 86: 1218-1240, 1995.
12. Spector GJ, Sessions DG, Emami B et al: Squamous cell carcinoma of the pyriform sinus: A nonrandomized comparison of therapeutic modalities and long term results. Laryngoscope 105: 397-406, 1995.
13. Hartley BE, Bottril ID and Howard DJ: A third decade's experience with the gastric pull-up operation for hypopharingeal carcinoma: chancing patterns of use. J Laryngol Otol 113: 241-243, 1999.
14. Chevalier D, Triboulet JP, Petenotre P and Louguet F: Free jejunal graft reconstruction after total pharyngolaryngeal resection for hypopharingeal cancer. Clin Otolaryngol 22: 41-43, 1997.
15. Johansen LV, Grau C and Overgaard J: Hypopharyngeal squamous cell carcinoma-treatment results in 138 consecutively admitted patients. Acta Oncol 39: 529-536, 2000.
16. Bataini P, Brugere J and Berniere J: Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus. Int J Radiat Oncol Biol Phys 8: 1277, 1982.
17. Dubois JB, Guerrier B, Di Ruggiero JM et al: Cancer of the pyriform sinus: Treatment by radiation therapy alone and after surgery. Radiology 160: 831, 1986.
18. Gavilan J, Prim MP, Hardisson D, De Diegi JI and Pozuelo A: Postoperative radiotherapy in patients with positive nodes after functional neck dissection. Ann Otol Rhinol Laryngol 109: 844-848, 2000.
19. Mendenhall WM, Million RR and Cassissi NJ: Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 12: 733-740, 1986.
20. Parson TJ, Mendenhall WM, Cassissi NJ and Stringer SP: Million RR. Neck dissection after twice-a-day radiotherapy: morbidity and recurrence rates. Head Neak 11: 400-404, 1989.
21. Peters LJ, Weber RS, Morrison WH, Byers RM, Garden AS and Goepfert H: Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 18: 552-55, 1999.
22. Grabenbauer GG, Rödel C, Ernest-Stecken A, Brunner T, Hornung J, Kittel K, Steinhart H, Iro H, Sauer R and Schultze-Mosgau S: Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only. Radiat Oncol 66: 57-63, 2003.
23. Dagum P, Pinto HA and Newman JP: Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Am J Surg 176: 448-452, 1988.
24. Lavertu P, Adelstein DJ and Saxton JP: Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 19: 559-566, 1997.
25. Newkirk KA, Cullen KJ, Harter KW, PicKen CA, Sessions RB and Davidson BJ: Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck 23: 73-79, 2001.
26. Steason KM, Haraf DJ and Pelzer H: The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasability of selective neck dissection. Arch Otolaryngol Head Neck Surg 126: 950-956, 2000.
27. Wanebo H, Chougule P, Ready N et al: Surgical resection is necessary to maximize tumour control in functional-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 8: 644-650, 2001.
28. Pignon JP, Bourhis J, Domenge C and Designe L: Chemotherapy added to local treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Metaanalysis of chemotherapy on head and neck cancer. Lancet 355: 949-955, 2000.
29. Beauvillain C, Mahè M, Bourdin S et al: Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in local advanced respectable hypopharyngeal carcinomas. Laryngoscope 107: 648-53, 1997.
30. Hendry JH, Bentzen SM, Dale RG et al: A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) 8: 297-307, 1996.
31. Mackenzie RG, Hodson DI, Browman GP, Zuraw L and the Head and Neck Cancer Disease Site Group: Accelerated Radiotherapy for locally advanced Squamous Cell Carcinoma of Head and Neck (Practice Guideline Report No. 5-6c); Cancer Care Ontario Practice Guideline Initiative. http://www.ccopebc.ca/guidelines/head/cpg5_6bf.html.
32. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48: 7-16, 2000.
33. Overgard J, Sand Hansen H, Grau C, Overgard M, Specht L, Bastholt E et al: The DAHANCA 6 & 7 trial. A randomized multicenter study of 5 versus 6 fractions per week of conventional radiotherapy of squamous cell carcinoma of the head and neck [abstract]. Radioter Oncol 56 (suppl 1): S4, Abstract 8, 2000.
34. Skladowski K, Maciejewski B, Golden M, Pilecki B, Przeorek W and Tarnawski R: Randomized clinical trial on 7-day continuous accelerated irradiation (CAIR) of the head and neck cancer - report on 3-year tumour control and normal tissue toxicity. Radioter Oncol 55: 101-10, 2000.
35. Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroerer M, Flentje M, Eckel HE and Mueller RP: Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-Results of a multicentric randomized german trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 50: 1161-1171, 2001.
36. Morris MM, Schmidt-Ullrich RK, Di Nardo L, Manning MA, Silverman L, Clay L, Johnson CR and Amir C: Accelerate superfractionated radiotherapy with concomitant boost for locally advanced head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 52: 918-928, 2002.